'Personalized medicine' to identify genetic risks for type 2 diabetes and focus prevention: can it fulfill its promise?

Abstract excerpt

Public health measures are required to address the worldwide increase in type 2 diabetes. Proponents of personalized medicine predict a future in which disease treatment and, more important, prevention will be tailored to high-risk individuals rather than populations and will be based on genetic and other new biomarker tests. Accurate biomarker tests to identify people at risk for diabetes could allow...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cohort Studies
• Share to Diabetes Mellitus, Type 2
• Share to Genetic Predisposition to Disease